{"id":"W4406869295","doi":"10.1200/jco.2025.43.4_suppl.6","title":"GOBLET platform study: Preliminary safety and tumor response results for the relapsed anal carcinoma cohort in patients treated with pelareorep and atezolizumab.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Cohort; Oncology; Internal medicine; Carcinoma; Surgery; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002693109,0.000920339,0.001508326,0.0004721403,0.0003167363,0.001210691,0.0006442275,0.001122643,0.003754828],"category_scores_gemma":[0.002259813,0.0002699961,0.001958902,0.0004732005,0.0006172577,0.00102515,0.0007353475,0.001580964,0.0008514735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006955874,"about_ca_system_score_gemma":0.001066633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007435782,"about_ca_topic_score_gemma":0.001750887,"domain_scores_codex":[0.9991313,0.0003749102,0.00004565229,0.0001814861,0.0001505614,0.0001161615],"domain_scores_gemma":[0.998076,0.0003814841,0.0004933072,0.0002231742,0.0001366781,0.0006893215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6761428,0.01256969,0.15993,0.001398925,0.00528428,0.001205829,0.0007164332,0.001810224,0.02590807,0.0002431662,0.00710313,0.1076874],"study_design_scores_gemma":[0.2212014,0.3578367,0.3958,0.0002146034,0.003958585,0.00278048,0.000358816,0.001595053,0.005123444,0.0004952189,0.01050431,0.0001312505],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920599,0.002077586,0.0002684174,0.0002814845,0.00004592252,0.0007657717,0.002995751,0.00006311511,0.001442035],"genre_scores_gemma":[0.9812346,0.001388691,0.0008980207,0.0006584409,0.0001670453,0.001275422,0.0121992,0.00005889897,0.002119687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003754828,"threshold_uncertainty_score":0.01424265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04289859851674939,"score_gpt":0.3750636194387777,"score_spread":0.3321650209220283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}